These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1983349)
1. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man. Nwokolo CU; Sawyerr A; Smith JT; Pounder RE Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349 [TBL] [Abstract][Full Text] [Related]
2. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345 [TBL] [Abstract][Full Text] [Related]
3. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Smith JT; Gavey C; Nwokolo CU; Pounder RE Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine. Weingart J; Kunert H; Ottenjann R Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784 [TBL] [Abstract][Full Text] [Related]
5. Loss of acid suppression during dosing with H2-receptor antagonists. Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344 [TBL] [Abstract][Full Text] [Related]
6. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin. Rogers MJ; Holmfield JH; Primrose JN; Johnston D Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347 [TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat. Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740 [TBL] [Abstract][Full Text] [Related]
8. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man. Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082 [TBL] [Abstract][Full Text] [Related]
9. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers. Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051 [TBL] [Abstract][Full Text] [Related]
10. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465 [TBL] [Abstract][Full Text] [Related]
11. Effect of oral famotidine on 24-hour intragastric acidity. Santana IA; Lanzon-Miller S; Pounder RE Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150 [TBL] [Abstract][Full Text] [Related]
12. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Gavey CJ; Smith JT; Nwokolo CU; Pounder RE Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500 [TBL] [Abstract][Full Text] [Related]
13. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding. Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626 [TBL] [Abstract][Full Text] [Related]
14. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding. Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo. Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195 [TBL] [Abstract][Full Text] [Related]
16. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects. Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190 [TBL] [Abstract][Full Text] [Related]
17. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine. Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782 [TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Lachman L; Howden CW Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559 [TBL] [Abstract][Full Text] [Related]
19. The new histamine H2-receptor antagonist ranitidine. Duration of action. Dammann HG; Simon B Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781 [TBL] [Abstract][Full Text] [Related]